Paper Details

  1. Home
  2. Paper Details

Clinical trial results of new therapies for HBV: implications for treatment guidelines.

Author: GishRobert G

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

This article explores new treatments for chronic hepatitis B virus (HBV) infection. The current approved therapies are limited by low sustained response rates, side effects, and drug resistance. Newer agents like entecavir and pegylated interferons offer increased potency and reduced resistance potential. Several promising anti-HBV agents in phase II clinical trials, such as tenofovir, clevudine, telbivudine, pradefovir, and valtorcitabine, show potential for future treatment options.
Paper Details　
Original Abstract of the Article :
Currently approved treatments for chronic infection with hepatitis B virus (HBV) are limited by low rates of sustained response, side effects, and in some cases, the emergence of drug resistance. Thus, new treatments, characterized by more potent antiviral effects less toxicity, and minimal or no ri...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1055/s-2005-915648

データ提供：米国国立医学図書館（NLM）

New Therapies for Hepatitis B: Navigating the Desert of Chronic Infection

Hepatitis B virus (HBV) infection is a significant global health concern, affecting millions worldwide. Current treatments for chronic HBV infection have limitations, such as low cure rates, side effects, and drug resistance. This research explores the development of new antiviral agents that offer improved efficacy and safety. It's like searching for a hidden oasis in the desert, seeking a cure for a persistent and debilitating disease.

Promising New Therapies

The study reviews the clinical experience with new antiviral agents, including entecavir, pegylated interferons, and other promising candidates like tenofovir and clevudine. These agents show increased potency and reduced potential for resistance, offering hope for better treatment outcomes. It's like discovering a new breed of camels that can navigate the desert more efficiently and with fewer risks.

A Path Towards Effective Treatment

This research highlights the ongoing progress in the development of new therapies for chronic HBV infection. It underscores the importance of continued research and clinical trials to identify safe and effective treatment options. It's like mapping out a new route through the desert, seeking a path that leads to a cure for this challenging disease.

Dr.Camel's Conclusion

This research provides a glimpse into the evolving landscape of HBV treatment, offering hope for more effective and less toxic therapies. It emphasizes the importance of continued research and clinical trials to identify new and innovative solutions. It's a reminder that even in the vast and sometimes unforgiving desert of infectious diseases, perseverance and scientific innovation can lead to breakthroughs that benefit millions.

Date :
  1. Date Completed 2005-11-29
  2. Date Revised 2007-11-15
Further Info :

Pubmed ID

16103979

DOI: Digital Object Identifier

10.1055/s-2005-915648

Related Literature

Article Analysis
・Side Effects of telbivudine
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.